Abstract:Background: Acute myeloid leukemia (AML) is a clonal malignant disease with poor prognosis and a low overall survival rate. Although many studies on the treatment and detection of AML have been conducted, the molecular mechanism of AML development and progression has not been fully elucidated. The present study was designed to pursuit the molecular mechanism of AML using a comprehensive bioinformatics analysis, and build an applicable model to predict the survival probability of AML patients in clinical use.Methods: To simplify the complicated regulatory networks, we performed the gene co-expression and PPI network based on WGCNA and STRING database using modularization design. Two machine learning methods, A least absolute shrinkage and selector operation (LASSO) algorithm and support vector machine-recursive feature elimination (SVM-RFE), were used to filter the common hub genes by five-fold cross-validation. The candidate hub genes were used to build the predictive model of AML by the cox-proportional hazards analysis, and validated in The Cancer Genome Atlas (TCGA) cohort and ohsu cohort, which were reliable in the experimental verification by qRT-PCR and western blotting in mRNA and protein levels.Results: Three hub genes, FLT3, CD177 and TTPAL were used to build a clinically applicable model to predict the survival probability of AML patients and divided them into high and low groups. To compare the survival ability of the model with the classical clinical features, we generated the nomogram. The model displayed the most risk points contrast to other clinical characteristics, which was compatible with the data of cox multivariate regression.Conclusion: This study reveal the novel molecular mechanism of AML, and construct a clinical model significantly related to AML patient prognosis. We showed the integrated roles of critical pathways, hub genes associated, which provide potential targets and new research ideas for the treatment and early detection of AML.

Study on Leukemia Molecular Prediction Model with Gene Expression Profile

Network Biomarkers Constructed from Gene Expression and Protein-Protein Interaction Data for Accurate Prediction of Leukemia.

Predicting Disease Genes of Leukemia by Using Similar Significant Sequence Features

A Robust Statistical Procedure to Discover Expression Biomarkers Using Microarray Genomic Expression Data.

Survival prediction in acute myeloid leukemia using gene expression profiling

Gene Selection for Leukemia Subtype Classification from Gene Expression Profile

Identification of Leukemia Stem Cell Expression Signatures Through Monte Carlo Feature Selection Strategy and Support Vector Machine

Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia

Molecular Diagnosis of Tumor Based on Independent Component Analysis and Support Vector Machines

Study of tumor molecular diagnosis model based on artificial neural network with gene expression profile

Gene Differential Expression Analysis for Leukemia Based on Relative Risk

Selection of Feature Genes in Cancer Clsssification

Super learner model for classifying leukemia through gene expression monitoring

Cancer Subtype Recognition and Feature Selection with Gene Expression Profiles

Feature genes predicting the FLT3/ITD mutation in acute myeloid leukemia

Integrative Analysis of Gene Expression Data by RNA Sequencing for Differential Diagnosis of Acute Leukemia: Potential Application of Machine Learning

Mining Leukemia Gene Association Structure with DNA Microarray

Cancer Molecular Classification Based on Support Vector Machines

A Method for Cancer Classification Using Ensemble Neural Networks with Gene Expression Profile

Leukemia Candidate Genetic Markers-An Evaluation

Convergent learning-based model for leukemia classification from gene expression